Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Budde

Showing results (31-40 of 155) with videos related to

Pageof 16
Sort By:
Transplantation Proceedings|December 10, 2016
Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant PatientsS Brakemeier, M Dürr, F Bachmann, et al.
Clinical Transplantation|March 13, 2014
Acute cellular rejection with isolated v-lesions is not associated with more favorable outcomes than vascular rejection with more tubulointerstitial inflammationsK Y Wu, K Budde, D Schmidt, et al.
Transplantation Proceedings|August 15, 2002
Cyclosporine absorption profiling and therapeutic drug monitoring using C(2) blood levels in stable renal allograft recipientsG Einecke, I Mai, F Diekmann, et al.
Transplantation Proceedings|March 26, 2004
FTY720: early clinical experienceD Dragun, L Fritsche, T Boehler, et al.
Acta Physiologica (Oxford, England)|July 31, 2016
Biomarkers in acute kidney injury - pathophysiological basis and clinical performanceE V Schrezenmeier, J Barasch, K Budde, et al.
Transplantation Reviews (Orlando, Fla.)|September 29, 2015
Need for optimized immunosuppression in elderly kidney transplant recipientsL J Lehner, Oliver Staeck, Fabian Halleck, et al.
Journal of the American Society of Nephrology : JASN|December 10, 1999
Volume stress-induced peritoneal endothelin-1 release in continuous ambulatory peritoneal dialysisS Morgera, S Kuchinke, K Budde, et al.
Transplantation Proceedings|December 26, 2001
Prostaglandin E(1) inhibits cyclosporine A-induced upregulation of transforming growth factor-beta 1 in rat mesangial cellsK Dell, T Böhler, J Gaedeke, et al.
European Journal of Medical Research|June 11, 2005
Pharmacokinetics of the immunosuppressant everolimus in maintenance renal transplant patientsK Budde, L Fritsche, J Waiser, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Pharmacodynamics of FTY720, the first member of a new class of immune-modulating therapeutics in transplantation medicineT Böhler, J Waiser, M Schütz, et al.
Pageof 16

Showing results (31-40 of 155) with videos related to

Sort By:
Pageof 16
Transplantation Proceedings|December 10, 2016
Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant PatientsS Brakemeier, M Dürr, F Bachmann, et al.
Clinical Transplantation|March 13, 2014
Acute cellular rejection with isolated v-lesions is not associated with more favorable outcomes than vascular rejection with more tubulointerstitial inflammationsK Y Wu, K Budde, D Schmidt, et al.
Transplantation Proceedings|August 15, 2002
Cyclosporine absorption profiling and therapeutic drug monitoring using C(2) blood levels in stable renal allograft recipientsG Einecke, I Mai, F Diekmann, et al.
Transplantation Proceedings|March 26, 2004
FTY720: early clinical experienceD Dragun, L Fritsche, T Boehler, et al.
Acta Physiologica (Oxford, England)|July 31, 2016
Biomarkers in acute kidney injury - pathophysiological basis and clinical performanceE V Schrezenmeier, J Barasch, K Budde, et al.
Transplantation Reviews (Orlando, Fla.)|September 29, 2015
Need for optimized immunosuppression in elderly kidney transplant recipientsL J Lehner, Oliver Staeck, Fabian Halleck, et al.
Journal of the American Society of Nephrology : JASN|December 10, 1999
Volume stress-induced peritoneal endothelin-1 release in continuous ambulatory peritoneal dialysisS Morgera, S Kuchinke, K Budde, et al.
Transplantation Proceedings|December 26, 2001
Prostaglandin E(1) inhibits cyclosporine A-induced upregulation of transforming growth factor-beta 1 in rat mesangial cellsK Dell, T Böhler, J Gaedeke, et al.
European Journal of Medical Research|June 11, 2005
Pharmacokinetics of the immunosuppressant everolimus in maintenance renal transplant patientsK Budde, L Fritsche, J Waiser, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 6, 2004
Pharmacodynamics of FTY720, the first member of a new class of immune-modulating therapeutics in transplantation medicineT Böhler, J Waiser, M Schütz, et al.
Pageof 16